Analysis of the Clinical Risk Factors of No-reflow in Elderly Patients with ST-segment Elevation in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

被引：0
|
作者：
Fu, W. B. [1 ]
Ding, S. F. [1 ]
机构：
[1] PLA, Wuhan Gen Hosp, Dept Cardiol, Wuhan 430070, Peoples R China
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2015年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P7
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [21] The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Quisi, Alaa
    Alici, Gokhan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (09)
  • [22] NO-REFLOW PHENOMENON DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION DUE TO MASSIVE CORONARY THROMBOSIS. PATHOGENESIS AND PREDICTORS OF NO-REFLOW
    Zhuravlev, A. S.
    Azarov, A. V.
    Semitko, S. P.
    Ioseliani, D. G.
    KARDIOLOGIYA, 2021, 61 (02) : 99 - 105
  • [23] Machine learning prediction of no reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Wang, Lin
    Bao, Pei
    Wang, Xiaochen
    Xu, Banglong
    Liu, Zeyan
    Hu, Guangquan
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04)
  • [24] Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Nasef, M. A.
    Saber, M.
    Gomaa, Y.
    Kamal, D.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [25] Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention
    Bozbeyoglu, Emrah
    Satilmis, Seckin
    Aksu, Huseyin
    Yildirimturk, Ozlem
    Nurkalem, Zekeriya
    CORONARY ARTERY DISEASE, 2012, 23 (08) : 523 - 527
  • [26] Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches
    Zhang, Dongfeng
    Song, Xiantao
    Lv, Shuzheng
    Li, Dong
    Yan, Shuai
    Zhang, Min
    CORONARY ARTERY DISEASE, 2014, 25 (07) : 582 - 588
  • [27] Analysis on influential factors of prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    张宇晨
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (01) : 34 - 35
  • [28] Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
    Park, Soonyoung
    Lee, Jooyoung
    Lee, Sang Yeub
    Bae, Jang-Whan
    Hwang, Kyung-Kuk
    Kim, Dong-Woon
    Cho, Myeong-Chan
    Kim, Sang Min
    KOREAN CIRCULATION JOURNAL, 2013, 43 (08) : 557 - 560
  • [29] Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Jacobs, Joshua A.
    Pickworth, Kerry
    Boudoulas, Konstantinos Dean
    Hinkley, Megan
    McLaughlin, Eric
    Blais, Danielle
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (08) : 711 - 715
  • [30] Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Yan, Yan
    Gong, Wei
    Ma, Changsheng
    Wang, Xiao
    Smith, Sidney C., Jr.
    Fonarow, Gregg C.
    Morgan, Louise
    Liu, Jing
    Vicaut, Eric
    Zhao, Dong
    Montalescot, Gilles
    Nie, Shaoping
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) : 251 - 263
12345